Cathérine Dubos

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Denis Moro‐Sibilot, Nathalie Cozic, M. Pérol et al. · Annals of Oncology · 2019 · 194 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

Élisa Gobbini, Anne Claire Toffart, M. Pérol et al. · Clinical Lung Cancer · 2020 · 76 citations · Full text

Life Sciences, Immunology, Oncology +12

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network

Jordi Remón, Nicolas Girard, Julien Mazières et al. · Lung Cancer · 2016 · 73 citations

Medicine, Oncology, Pharmacotherapy +12

OP0196 Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune diseases: a nationwide multicenter retrospective study

Alice Tison, Gilles Quéré, L. Misery et al. · Annals of the Rheumatic Diseases · 2018 · 12 citations · Full text

Life Sciences, Immunology, Oncology +14